Abstract
Of six new oral cephalosporins, cefixime and cefpodoxime were the most active (MIC for 90% of isolates tested [MIC90], 16 micrograms/ml) against Bordetella pertussis, followed by cefetamet, cefprozil, and loracarbef (LY163892) (MIC90, 64 micrograms/ml) and ceftibuten (MIC90, 128 micrograms/ml). Against Bordetella parapertussis, loracarbef was more active (MIC90, 32 micrograms/ml) than the other compounds tested (MIC90s, 64 to greater than 128 micrograms/ml). The new oral cephalosporins are unlikely to play a role in pertussis treatment.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bannatyne R. M., Cheung R. Susceptibility of Bordetella pertussis to cephalosporin derivatives and imipenem. Antimicrob Agents Chemother. 1984 Oct;26(4):604–605. doi: 10.1128/aac.26.4.604. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hoppe J. E., Eichhorn A. Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis. Eur J Clin Microbiol Infect Dis. 1989 Jul;8(7):653–654. doi: 10.1007/BF01968151. [DOI] [PubMed] [Google Scholar]
- Hoppe J. E., Haug A., Botzenhart K. Susceptibility of Bordetella pertussis and Bordetella parapertussis to 24 antibiotics. Chemotherapy. 1987;33(4):250–254. doi: 10.1159/000238503. [DOI] [PubMed] [Google Scholar]
- Simon C. In vitro activity of Ro 15-8074 and Ro 19-5247 in comparison to cefaclor and cefalexin. Infection. 1987 Mar-Apr;15(2):122–124. doi: 10.1007/BF01650213. [DOI] [PubMed] [Google Scholar]
- Sutcliffe E. M., Abbott J. D. Selective medium for the isolation of bordetella pertussis and parapertussis. J Clin Pathol. 1972 Aug;25(8):732–733. doi: 10.1136/jcp.25.8.732. [DOI] [PMC free article] [PubMed] [Google Scholar]